Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Satralizumab for Children with Neuromyelitis Optica Spectrum Disorder (NMOSD)

    Recruiting

    3 1 1
    Investigated Drugs:
    France Italy Poland
  • Study of Bictegravir and Lenacapavir for Children and Adolescents with HIV-1

    Recruiting

    4 1 1 1
    Investigated Drugs:
    Italy Spain
  • Study on INZ-701 for Improving Survival in Infants with ENPP1 Deficiency

    Recruiting

    3 1 1
    France Hungary Italy Spain Sweden
  • Study of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia Denmark Finland Germany +4
  • Study on CART 19/22 T Cells and CART45RA-NKG2D Cells for Treating Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents, and Young Adults

    Recruiting

    1 1 1
    Spain
  • Study on the Safety and Effectiveness of Zilovertamab Vedotin for Children and Young Adults with Blood Cancers or Solid Tumors

    Recruiting

    1 1 1
    Investigated Drugs:
    Belgium Czechia Denmark France Germany Greece +6
  • Study of CD7-CART01, Cyclophosphamide, and Fludarabine Phosphate for Children and Young Adults with Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma

    Recruiting

    2 1 1 1
    Italy
  • Study on the Effects of Iptacopan in Patients with Idiopathic Membranoproliferative Glomerulonephritis (IC-MPGN)

    Recruiting

    3 1
    Czechia Denmark France Germany Greece Italy +4
  • Study Comparing Subcutaneous and Intravenous Nivolumab and Relatlimab for Patients with Untreated Metastatic or Unresectable Melanoma

    Recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Czechia Finland France Germany +5
  • Study on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis

    Recruiting

    3 1 1 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia Italy Poland Portugal +1